Stephane Pichon

I assist healthcare operators (long-term care, acute, lab ...) and investors in their development: consulting, finance, real estate, technology.

• Managed healthcare real estate financings and investments in South-Western Europe. • Led two relationship managers respectively focused on Spain and Italy. • Took minority equity stake in Gecimed, Europe’s first healthcare-dedicated Real Estate Investment Trust.

• Managed origination and execution of European acquisitions in IT, cardiology, molecular imaging. • Managed origination and execution of European acquisitions in IT, cardiology, molecular imaging. • Acquired Amersham, British leader in molecular medicine, for €9 billion. • Acquired Instrumentarium, Finnish leader in anaesthesia equipment, for €2 billion. • Acquired two GE Healthcare distributors to ensure direct presence in strategic markets (Scandinavia and Middle East).

Led 12-member team focusing on the origination and execution of deals in France. • Advised biotech company on a dual track IPO vs. sale to a strategic buyer. • Participated on team that acted as principal along with two financial partners to acquire property development company CGIS, subsequently renamed Nexity, for €850 million. • Advised leading French ISP Wanadoo on €2.7 billion recommended offer for leading UK ISP Freeserve. • Advised Zodiac on the €460 million acquisition (public takeover and squeeze

• Led €1.1 billion Rhône-Poulenc (now part of Sanofi-Aventis) spin-off and IPO of Rhodia (dual Paris / NYSE listing) and advised on pre-IPO disposal of its PCC business. • Advised biotech company on capital raising exercise through convertible bonds. • Performed two fairness opinions for Suez on transactions aggregating €1 billion.

• Managed 9-member team that designed and prepared inaugural report on Park’s activiti • Participated in formulation of business plans, which resulted in a profit turnaround of $1.1 billion. • Led task force to streamline staff recruiting and scheduling procedures as part of a business process re-engineering program that reduced operating costs by $60 million. • Developed statistical models that enhanced accuracy of weekly attendance forecasts by 15% and reduced analysis time of Pan-European customer profil

• In charge of accounting, financial controlling, budgeting and monthly reporting to Parent Company.